Dymista Nasal Spray Dosing Guidelines

FDA-Approved Dosing

The American Academy of Otolaryngology-Head and Neck Surgery recommends a dose of 1 spray per nostril twice daily for patients 12 years and older with seasonal allergic rhinitis 1, 2
Each spray delivers 137 µg of azelastine hydrochloride and 50 µg of fluticasone propionate, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 1, 2
Dymista is not approved for children under 12 years of age, according to the American Academy of Otolaryngology-Head and Neck Surgery 1, 2

The combination of azelastine and fluticasone provides more than 40% greater symptom reduction compared to fluticasone propionate alone, representing a clinically meaningful improvement over single-agent therapy, as reported by Praxis Medical Insights 3, 4

Bitter taste is the most common side effect, which can be minimized with proper technique, as noted by the American Academy of Otolaryngology-Head and Neck Surgery 1, 2
Epistaxis, headache, and somnolence are also common side effects, according to the American Academy of Otolaryngology-Head and Neck Surgery 1, 2

The American Academy of Otolaryngology-Head and Neck Surgery advises against using Dymista as first-line therapy, instead recommending intranasal corticosteroids alone as initial treatment for allergic rhinitis 3
Onset of action occurs within 12-24 hours, but maximal efficacy requires days to weeks of regular use, as reported by Praxis Medical Insights 4, 5
Dymista is maintenance therapy, not rescue therapy, and should be continued regularly even when symptoms improve, according to Praxis Medical Insights 3